Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia

Angela Huynh, Donald M. Arnold, James W. Smith, Rumi Clare, Nikola Ivetic, Jane C. Moore, John G. Kelton, Ishac Nazy

Blood (2022) 140 (Supplement 1): 5640–5641.

https://doi.org/10.1182/blood-2022-167607

Published: 2022

Journal Articles

Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia

Angela Huynh, BSc, Donald M. Arnold, MD MSc, FRCPC, James W. Smith, Taylor D. Elliott, BSc, Hina Bhakta, John G. Kelton, MD, Ishac Nazy, PhD

Blood (2018) 132 (Supplement 1): 3746.

https://doi.org/10.1182/blood-2018-99-115037

Published: 2018

Journal Articles

Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia

Nikola Ivetic, BSc, James W. Smith, Angela Huynh, BSc, John G Kelton, MD FRCPC, Donald M Arnold, MD, Ishac Nazy, PhD

Blood (2017) 130 (Supplement 1): 3615.

https://doi.org/10.1182/blood.V130.Suppl_1.3615.3615

Published: 2017

Journal Articles

Autoantibodies to Thrombopoietin and the Thrombopoietin Receptor in Patients with Immune Thrombocytopenia

Ishac Nazy, PhD, Jane C. Moore, BSc, MT, Rumi Clare, B.Sc., James W. Smith, BSc MT, Nikola Ivetic, BSc, Vanessa D'Souza, B.Sc., John G. Kelton, MD FRCPC, Donald M. Arnold, MD

Blood (2016) 128 (22): 2548.

https://doi.org/10.1182/blood.V128.22.2548.2548

Published: 2016

Journal Articles

Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test

Ishac Nazi, PhD, Donald M Arnold, MD, James W Smith, BSc, MT, Theodore E. Warkentin, MD, Jane C Moore, BSc, MT, Peter Horsewood, PhD, John G. Kelton, MD FRCPC

Blood (2014) 124 (21): 2757.

https://doi.org/10.1182/blood.V124.21.2757.2757

Published: 2014

Journal Articles

Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial

Ishac Nazi, Ph.D., John G. Kelton, MD, FRCPC, Mark Larche, Ph.D., Denis P. Snider, Ph.D., Jane C. Moore, B.Sc., James W. Smith, B.Sc., Rumi Clare, B.Sc., Diana M. Moffatt, Joecyln Tufts, Donald M. Arnold, MD, MSc.

Blood (2012) 120 (21): 492.

https://doi.org/10.1182/blood.V120.21.492.492

Published: 2012

Journal Articles

Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,

Donald M. Arnold, MD, Theodore E. Warkentin, MD, James W. Smith, BSc, Aliya Esmail, Sadiya Kukaswadia, MD, Lori Dewar, John G. Kelton, MD, FRCPC

Blood (2011) 118 (21): 3304.

https://doi.org/10.1182/blood.V118.21.3304.3304

Published: 2011

Journal Articles

Collection and Storage of Apheresis Platelets Results in a Significant Decline in the Percentage of Coated-Platelets.

Roseleen Charania, MBBS, MD, James W Smith, MD, PhD, Sara K. Vesely, PhD, George L. Dale, PhD, Jennifer L. Holter, MD

Blood (2009) 114 (22): 23.

https://doi.org/10.1182/blood.V114.22.23.23

Published: 2009

Journal Articles

Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins.

James W Smith, BSc, MT, Derek Coull, BSc, Jane C Moore, BSc, MT, Ishac Nazi, PhD, Donald M. Arnold, MD, John G. Kelton, MD, FRCPC

Blood (2008) 112 (11): 3427.

https://doi.org/10.1182/blood.V112.11.3427.3427

Published: 2008

Journal Articles

Long-Term Increases in Lymphocytes and Platelets in Human T-Lymphotropic Virus Type II Infection

Melissa T Bartman, MPH, Zhanna Kaidarova, PhD, Dale Hirschkorn, Ronald A. Sacher, MD, Joy Fridey, MD, George Garratty, PhD, FRCPath, Joan Gibble, MD, James W Smith, MD, PhD, Bruce Newman, MD, Anthony E Yeo, MD, PhD, Edward L Murphy, MD, MPH

Blood (2008) 112 (11): 4900.

https://doi.org/10.1182/blood.V112.11.4900.4900

Published: 2008

Journal Articles

Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection

Melissa T. Bartman, Zhanna Kaidarova, Dale Hirschkorn, Ronald A. Sacher, Joy Fridey, George Garratty, Joan Gibble, James W. Smith, Bruce Newman, Anthony E. Yeo, Edward L. Murphy

Blood (2008) 112 (10): 3995–4002.

https://doi.org/10.1182/blood-2008-05-155960

Published: 2008

Includes: Supplemental data

Journal Articles

Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.

James W. Smith, BSc, Kristen Chamberlain, BSc, Diana Moffatt, MLT, Aurelio Santos, BSMT, Denise Neutel, MLT, Jane Moore, BSc, Theodore E. Warkentin, MD, Donald M. Arnold, MD, John G. Kelton, MD

Blood (2007) 110 (11): 3214.

https://doi.org/10.1182/blood.V110.11.3214.3214

Published: 2007

Journal Articles

An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.

Donald M. Arnold, MD, MSc, Jane C. Moore, James W. Smith, John G. Kelton, MD

Blood (2007) 110 (11): 3926.

https://doi.org/10.1182/blood.V110.11.3926.3926

Published: 2007

Journal Articles

The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.

Kristen Chamberlain, James W. Smith, BSc, MLT, Diana Moffatt, MLT, Jane Moore, BSc, MLT, Donald Arnold, MD, John G. Kelton, MD

Blood (2005) 106 (11): 2180.

https://doi.org/10.1182/blood.V106.11.2180.2180

Published: 2005

NARROW

Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia

Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia

Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia

Autoantibodies to Thrombopoietin and the Thrombopoietin Receptor in Patients with Immune Thrombocytopenia

Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test

Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial

Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,

Collection and Storage of Apheresis Platelets Results in a Significant Decline in the Percentage of Coated-Platelets.

Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins.

Long-Term Increases in Lymphocytes and Platelets in Human T-Lymphotropic Virus Type II Infection

Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection

Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.

An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.

The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only